Lipid Horizons: Recent Advances and Future Prospects in LBDDS for Oral Administration of Antihypertensive Agents

The lipid-based drug delivery system (LBDDS) is a well-established technique that is anticipated to bring about comprehensive transformations in the pharmaceutical field, impacting the management and administration of drugs, as well as treatment and diagnosis. Various LBDDSs verified to be an effica...

Full description

Bibliographic Details
Main Authors: null Preeti, Sharda Sambhakar, Rohit Malik, Saurabh Bhatia, Ahmed Al Harrasi, Renu Saharan, Geeta Aggarwal, Suresh Kumar, Renu Sehrawat, Chanchal Rani
Format: Article
Language:English
Published: Wiley 2024-01-01
Series:International Journal of Hypertension
Online Access:http://dx.doi.org/10.1155/2024/2430147
_version_ 1826826008155652096
author null Preeti
Sharda Sambhakar
Rohit Malik
Saurabh Bhatia
Ahmed Al Harrasi
Renu Saharan
Geeta Aggarwal
Suresh Kumar
Renu Sehrawat
Chanchal Rani
author_facet null Preeti
Sharda Sambhakar
Rohit Malik
Saurabh Bhatia
Ahmed Al Harrasi
Renu Saharan
Geeta Aggarwal
Suresh Kumar
Renu Sehrawat
Chanchal Rani
author_sort null Preeti
collection DOAJ
description The lipid-based drug delivery system (LBDDS) is a well-established technique that is anticipated to bring about comprehensive transformations in the pharmaceutical field, impacting the management and administration of drugs, as well as treatment and diagnosis. Various LBDDSs verified to be an efficacious mechanism for monitoring hypertension systems are SEDDS (self-nano emulsifying drug delivery), nanoemulsion, microemulsions, vesicular systems (transferosomes and liposomes), and solid lipid nanoparticles. LBDDSs overcome the shortcomings that are associated with antihypertensive agents because around fifty percent of the antihypertensive agents experience a few drawbacks including short half-life because of hepatic first-pass metabolism, poor aqueous solubility, low permeation rate, and undesirable side effects. This review emphasizes antihypertensive agents that were encapsulated into the lipid carrier to improve their poor oral bioavailability. Incorporating cutting-edge technologies such as nanotechnology and targeted drug delivery, LBDDS holds promise in addressing the multifactorial nature of hypertension. By fine-tuning drug release profiles and enhancing drug uptake at specific sites, LBDDS can potentially target renin-angiotensin-aldosterone system components, sympathetic nervous system pathways, and endothelial dysfunction, all of which play crucial roles in hypertension pathophysiology. The future of hypertension management using LBDDS is promising, with ongoing reviews focusing on precision medicine approaches, improved biocompatibility, and reduced toxicity. As we delve deeper into understanding the intricate mechanisms underlying hypertension, LBDDS offers a pathway to develop next-generation antihypertensive therapies that are safer, more effective, and tailored to individual patient needs.
first_indexed 2024-03-07T21:29:38Z
format Article
id doaj.art-50db3b496fb84813a48235da8f2e8e9c
institution Directory Open Access Journal
issn 2090-0392
language English
last_indexed 2025-02-16T08:04:36Z
publishDate 2024-01-01
publisher Wiley
record_format Article
series International Journal of Hypertension
spelling doaj.art-50db3b496fb84813a48235da8f2e8e9c2025-02-03T05:55:28ZengWileyInternational Journal of Hypertension2090-03922024-01-01202410.1155/2024/2430147Lipid Horizons: Recent Advances and Future Prospects in LBDDS for Oral Administration of Antihypertensive Agentsnull Preeti0Sharda Sambhakar1Rohit Malik2Saurabh Bhatia3Ahmed Al Harrasi4Renu Saharan5Geeta Aggarwal6Suresh Kumar7Renu Sehrawat8Chanchal Rani9Banasthali VidyapithBanasthali VidyapithGurugram Global College of PharmacyNatural & Medical Sciences Research CentreNatural & Medical Sciences Research CentreBanasthali VidyapithBanasthali VidyapithBharat Institute of PharmacySchool of Medical & Allied SciencesGurugram Global College of PharmacyThe lipid-based drug delivery system (LBDDS) is a well-established technique that is anticipated to bring about comprehensive transformations in the pharmaceutical field, impacting the management and administration of drugs, as well as treatment and diagnosis. Various LBDDSs verified to be an efficacious mechanism for monitoring hypertension systems are SEDDS (self-nano emulsifying drug delivery), nanoemulsion, microemulsions, vesicular systems (transferosomes and liposomes), and solid lipid nanoparticles. LBDDSs overcome the shortcomings that are associated with antihypertensive agents because around fifty percent of the antihypertensive agents experience a few drawbacks including short half-life because of hepatic first-pass metabolism, poor aqueous solubility, low permeation rate, and undesirable side effects. This review emphasizes antihypertensive agents that were encapsulated into the lipid carrier to improve their poor oral bioavailability. Incorporating cutting-edge technologies such as nanotechnology and targeted drug delivery, LBDDS holds promise in addressing the multifactorial nature of hypertension. By fine-tuning drug release profiles and enhancing drug uptake at specific sites, LBDDS can potentially target renin-angiotensin-aldosterone system components, sympathetic nervous system pathways, and endothelial dysfunction, all of which play crucial roles in hypertension pathophysiology. The future of hypertension management using LBDDS is promising, with ongoing reviews focusing on precision medicine approaches, improved biocompatibility, and reduced toxicity. As we delve deeper into understanding the intricate mechanisms underlying hypertension, LBDDS offers a pathway to develop next-generation antihypertensive therapies that are safer, more effective, and tailored to individual patient needs.http://dx.doi.org/10.1155/2024/2430147
spellingShingle null Preeti
Sharda Sambhakar
Rohit Malik
Saurabh Bhatia
Ahmed Al Harrasi
Renu Saharan
Geeta Aggarwal
Suresh Kumar
Renu Sehrawat
Chanchal Rani
Lipid Horizons: Recent Advances and Future Prospects in LBDDS for Oral Administration of Antihypertensive Agents
International Journal of Hypertension
title Lipid Horizons: Recent Advances and Future Prospects in LBDDS for Oral Administration of Antihypertensive Agents
title_full Lipid Horizons: Recent Advances and Future Prospects in LBDDS for Oral Administration of Antihypertensive Agents
title_fullStr Lipid Horizons: Recent Advances and Future Prospects in LBDDS for Oral Administration of Antihypertensive Agents
title_full_unstemmed Lipid Horizons: Recent Advances and Future Prospects in LBDDS for Oral Administration of Antihypertensive Agents
title_short Lipid Horizons: Recent Advances and Future Prospects in LBDDS for Oral Administration of Antihypertensive Agents
title_sort lipid horizons recent advances and future prospects in lbdds for oral administration of antihypertensive agents
url http://dx.doi.org/10.1155/2024/2430147
work_keys_str_mv AT nullpreeti lipidhorizonsrecentadvancesandfutureprospectsinlbddsfororaladministrationofantihypertensiveagents
AT shardasambhakar lipidhorizonsrecentadvancesandfutureprospectsinlbddsfororaladministrationofantihypertensiveagents
AT rohitmalik lipidhorizonsrecentadvancesandfutureprospectsinlbddsfororaladministrationofantihypertensiveagents
AT saurabhbhatia lipidhorizonsrecentadvancesandfutureprospectsinlbddsfororaladministrationofantihypertensiveagents
AT ahmedalharrasi lipidhorizonsrecentadvancesandfutureprospectsinlbddsfororaladministrationofantihypertensiveagents
AT renusaharan lipidhorizonsrecentadvancesandfutureprospectsinlbddsfororaladministrationofantihypertensiveagents
AT geetaaggarwal lipidhorizonsrecentadvancesandfutureprospectsinlbddsfororaladministrationofantihypertensiveagents
AT sureshkumar lipidhorizonsrecentadvancesandfutureprospectsinlbddsfororaladministrationofantihypertensiveagents
AT renusehrawat lipidhorizonsrecentadvancesandfutureprospectsinlbddsfororaladministrationofantihypertensiveagents
AT chanchalrani lipidhorizonsrecentadvancesandfutureprospectsinlbddsfororaladministrationofantihypertensiveagents